The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@CooperD
“YGEN is solid”
I assume you mean the YGEN SP is ‘SOLIDLY’ stuck at around 17p, where is is today, and where it also sat etc 7 months ago on February 21st !! Rather unusual of a diagnostics company involved in the CoVid game, now 8 months into a global pandemic.
Not sure what global event your research has uncovered raising your anticipation of the YGEN SP being catapulted into the stratosphere, but if CoVid can’t do it, I for one struggle to think of one that can. Your research must be significantly better than mine. Or, making money on shares (regardless of asset) may not be your game !!! Fair enough if that’s the case.....
Couldn't agree more Steve67! Those were dark days. I remember the litigation RNS morning and the period of stagnation that followed very well.
Whatever your current concerns are, Lyn Rees deserves massive credit for digging us out of that particular hole and delivering a way forward with Illumina. The headwinds for the company have been significantly reduced in the last year or two.
pacman, you're lucky you missed the patent litigation and massive debt of the early Premaitha years!
Lyn got both of those sorted pretty quickly and got the company onto the solid growth path we see today.
Sure, it's not perfect now - no company ever is, and everyone on a BB could run it better, but by f**k it's a thousand times better than when Stephen Little was at the helm!
Cooper, nobody is crying, but there is nothing wrong with critique.
You also talk as though everyones investing Outlook should mirror your own.
We all have different priorities and goals and timelines.
Without critique, throughout life, nothing improves.
Ygen is not 100% perfect, so let's talk about the things they can improve, and if that prompts investors to communicate with the company then great.
By the way, if I came to a BB and saw nothing but cheerleaders with not a bad thing to say I would steer a million miles clear.
There is nothing wrong with critique.
Constantly talking up the share? Not me my friend. I'm constantly telling whingers to sell. I don't need to talk the share up. I know what's coming and I have a significant amount of money invested. Check my posts, I rarely post about the company because I don't feel the need to keep pumping it or talking it down. I do neither.
I could see your point if I was on here every day or so hammering home all the positives. I'm not. I know what this company will do if not hindered and that's why I am invested. The other stuff that you all cry about doesn't bother me.
I'm the type that will do my research, look at the end goal and ignore the noise in between times. I've already stated that a good evaluation period would be xmas time. Which will have given the company enough time to be in a position to report good numbers and figures that we all like. if that doesn't come to pass then I will evaluate why not and what my next move shall be.
Till then though, you won't see my crying about day to day, week to week fluctuations during a pandemic and a market thats all over the place.
Ygen is solid. dyor
pacman, I share your frustrations, jeeez, I've been here since Terry Bond days (oldies will know) so quite well used to it. One thing I have learned over the years is no matter how much I complained on this very same bb, and believe me I did with Bond et al, it got me precisely nowhere. All I did get was very hot under the collar, annoyed and high blood pressure to boot. In these pandemic times we have a growing company along many fronts, can't be all bad surely?
I am going to take a raincheck at xmas to see where we are with it all. I fully expect we will be well north of here if all comes to fruition along the way.
Agm will be interesting I think!
It's not talking it down Cooper.
It's asking genuine questions.
I am in the whole happy with my Ygen investment, but if there is an issue that I'm not happy with then I'll talk about it.
This BB isn't the sole domain for flag waveing head in the sand types.
If I go for a meal and I'm 90% happy with it but my steak is just a little overcooked then I will tell the waitress that the meal was in the whole lovely but the steak could have been a little rarer as I asked for.
I won't just say it was all great, so as not to upset anyone or make a scene.
I am 90% happy here with ygen, but there are just 1 or 2 issues that need addressing and talking about, with fellow investors, with walbrook, with the company if possible.
Let's see what the AGM and presentation brings.
@CooperD
CooperD,
As I sure you a well aware of, investing in any other diagnostics outfit than YGEN 6 months ago, would today have rewarded the investor many times better than YGEN.
Which makes one wonder what your motive is in constantly talking up this share in almost a bot-manner. And besides, I leave this board when I feel like it, and not because the default chief editor dislikes my comments. So I suggest you just get used to it. Many people here will be holding BECAUSE of you, and are now looking back at many lost alternative opportunities.....
Before posting all the upside down lip posts. ask yourself why am I holding? then spare us the drivel.
Next negative post must explain why they hold. :)
Investor relation are not there to hold your hand and guide you through your investment.
it's time to take some responsibility and own your investment. If you want to hold, then do so. If you are unhappy then sell.
It's one or the other, you can't sit here grumbling and complaining as that's a contradiction. Your money, your choice. nobody had made you hold, buy or sell.
Pacman,
this boards ends up the same every time. It's always the same posters. Sorry but it's time to leave the good ship Ygen otherwise what on earth is really going on here? why are there people holding and talking it down? I see this constantly and it goes against the every single rule of investing. Seriously, if people are unhappy they should simply sell and move on.
it does nothing for the investors looking in here to see all the negativity from people who clearly don't have the ability to give a timeframe for the outcome they are after or sell up and put it down to experience.
It really is as simple as that.
Absolutely pacman1
Spot on!
I'm quite sure people here aren't talking the stock down and would benefit hugely from an increasing share price as expected over the last x years.
It's very rare these days to get a reply from investor relations and the questions submitted for the agm I don't think will be made public and of course only a select few will be answered. I've submitted several btw.
I think all questions being asked are pretty genuine here. There are real concerns and I suspect that will be aired at the AGM tonight. BB aren't just for the knicker wetting cheerleading fan boys.
If these concerns were one offs no problem, but it's been a constant theme for many months.
It deserves to be talked about and not brushed aside by the can't do no wrong club.
Bakky, it was getting interesting in March. Then it was getting really interesting in April. By May it was so interesting I wet my knickers. In June it was off the charts in the interesting scale. Get my drift, its always the next month that's going to be interesting, or the next rns, yadda, yadda yadda.
I'm amazed by the negativity.
The share price hasn't rocketed, but take a step back and look at what is going on. This company is lined up to increase its revenue massively (at least in % terms) over the next few months and years. I understand the frustrations, as all the good news doesn't seem to be translating into share price uplift, but the facts are positive:
>> Launched a top-class Covid-19 PCR test and will be processing 10k tests monthly from October. That translates to £420k per month, or c.£5m per year.
>> They have confirmed they want to expand Covid-19 testing capacity and will do it in blocks of 10k. So that means with 'just' expansion of 10k tests, the Covid-19 test will be generating revenue of £10m annually. £15m if they do 30k tests, and so on. That's before you add in any revenue from the 500k additional capacity mentioned in the BRR media presentation. Covid-19 testing is likely to be required for years to come, so that's likely to be recurring revenue. Putting that into perspective, our total revenue for 2019-20 was £16.6m (which in itself was an 89% increase from the year before). Covid-19 testing, a new business line launched only a few months ago, could double our annual revenue in its first year.
>> We have launched the IONA NX test which allows us to sell to 60% of the global market which wasn't accessible before. This has the potential to double our 2019-20 NIPT revenue, if not more.
>> We have just started (or will shortly) the distribution of our products into the US market. Hard to quantify how much revenue this will be worth but I'd estimate it would be significant and build over time (they stated $30m in the RNS yesterday but that didn't cover all products, such as Covid-19 testing).
>> Our NIPT, oncology and reproductive business lines are all expected to achieve strong organic growth from the 2019-20 figures.
Put all of that together and you get a very significant increase in revenue for 2020-21 and beyond.
Not worried in the slightest. YGEN has been steadfast the past few months through countless uncertainties. Even seeing it sail through the bloodbath yesterday was very reassuring.
Patience will be rewarded. So many companies go for month or years within a narrow sp range and then rocket all of a sudden. Hopefully it will be the same here, and I don't see why not.
GLA!
Bakky,
Of course they won't be asking at the AGM. That doesn't achieve their objective. Their objective is to talk the stock down and buy more cheaper. Anyone with a genuine concern should be asking their question directly to the company not crying like an armature investor on the internet lol
Investors either trust the company to deliver or you don't. So, you either sell or you hold. Do it without crying though which ever way.
You'll never see an institutional investor crying, they simply sell. They are adult and professional though and big enough to walk away when it's required.
just as things are getting interesting peeps decide to sell, wtf!! Lemmings ahoy!! For people with all the questions, have or will you be asking any at the meeting or just continue your knicker wetting hysterics on a bb??
Sell, stop asking what others are doing, stop crying and sell :)
I bet you the slack will be taken up, don't let the door hit you on the way out.
This year thus far has been a year of building. if you don't like that fact then off you go. You have to build before they come.
When would these air miles have been clocked up during a global lockdown?
Still amazed people hanging on to this share. Where are the news of incoming cash ??
Happy for YGEN exec’s to clock up millions of air miles, but would expect something in return.
I’m not happy Twixter.
The communication from this company is criminal. Zero spin on it.
I don’t believe that we have made any ingress into the testing market whatsoever.
Caxton are quite busy I believe but that’s it.
Find somewhere else you can get our tests via a third party...
I’m hoping they announce something on this later - if not it’s time wasted and it’s criminal that they have wasted so much time.
I know for a fact that the generic normal swab used for collection is compatible with yourgene’s product (it’s a long cotton bud swab and a sample tube with liquid in it) - we should have had 10k now, right now by doing a deal to help take the slack.
Jam tomorrow.
The deal to supply Novacyt is dead. It was replaced by YGEN launching its own test. But not sure whether any revenue was generated from the deal up until the point it was killed off. I think LR confirmed it as part of the presentation Steve67 shared a few days ago.
https://webcasting.brrmedia.co.uk/broadcast/5f3a6136b14d872626437fb0
My hope is that this morning's update was NOT the quarterly Covid-19 testing update that has been promised, and rather that the quarterly update (including hard numbers and revenue figures) will come at the end of this month as it allows them to cover the full quarter (i.e. 1 July - 30 September). That is my hope.
The RNS contained the material news that we're due to hit 10k/month in the next couple of weeks and adding capacity.
Let's see how much more meat is put on the bones in the investor update later!
Fed up with this bhai so posting rarely nowadays.
I want to see the numbers and news but as is being expressed all too predictably it is not forthcoming. It's why over many years I have pointed it out. I want to see good pr and specifics numbers but we get general positive without numbers too often.
Was that the quarterly update?
Never going to hear what happened with novacyte!
I just don't see how investors are happy with the detail and figures we could be getting.